Pablo Tolosa

5PUBLICATIONS
40CO-AUTHORS
Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 26, 2026
Implementation of HER2DX Scores into Treatment Decisions in Early-Stage HER2-Positive Breast Cancer.

|Dec 01, 2025
Addition of Ipatasertib to Dual Anti-HER2 Maintenance Therapy in HER2-Positive Metastatic Breast Tumors with PIK3CA Mutations: The Phase Ib SOLTI-1507 IPATHER Trial.

Mafalda Oliveira, Eva Ciruelos, Guillermo Villacampa

|Apr 25, 2025
HER2DX ERBB2 mRNA score in first-line advanced HER2-positive breast cancer treated with chemotherapy, trastuzumab, and pertuzumab.

Rodrigo Sánchez-Bayona, Olga Martínez-Sáez, Denys Romero-Romero

|Apr 01, 2024
First-line therapy with palbociclib in patients with advanced HR+/HER2- breast cancer: The real-life study PALBOSPAIN.

N Martínez-Jañez, M Bellet Ezquerra, L M Manso Sanchez

|Mar 01, 2023
Circulating tumor DNA reveals complex biological features with clinical relevance in metastatic breast cancer.

Aleix Prat, Fara Brasó-Maristany, Olga Martínez-Sáez

Pageof 1

Frequent Collaborators

3 joint publications

Luis Manso

3 joint publications

Tomás Pascual

2 joint publications

Mafalda Oliveira

2 joint publications

Meritxell Bellet